Richard C. Yocum
2006 - Halozyme Therapeutics
In 2006, Richard C. Yocum earned a total compensation of $333.2K as Vice President — Clinical Development and Medical Affairs at Halozyme Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $36,000 |
|---|---|
| Option Awards | $56,968 |
| Salary | $240,000 |
| Other | $232 |
| Total | $333,200 |
Yocum received $240K in salary, accounting for 72% of the total pay in 2006.
Yocum also received $36K in non-equity incentive plan, $57K in option awards and $232 in other compensation.
Rankings
In 2006, Richard C. Yocum's compensation ranked 5,596th out of 7,022 executives tracked by ExecPay. In other words, Yocum earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,596 out of 7,022 | 20th |
Division Manufacturing | 1,934 out of 2,413 | 20th |
Major group Chemicals And Allied Products | 536 out of 673 | 20th |
Industry group Drugs | 398 out of 518 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 88 out of 112 | 21st |
Source: SEC filing on April 2, 2009.
Yocum's colleagues
We found five more compensation records of executives who worked with Richard C. Yocum at Halozyme Therapeutics in 2006.
2006
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2006
Gregory Frost
Halozyme Therapeutics
Chief Scientific Officer
2006
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2006
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2006
William Fallon
Halozyme Therapeutics